Exploring Structural Uncertainty in Model-Based Economic Evaluations
暂无分享,去创建一个
[1] N. Lazar,et al. Methods and Criteria for Model Selection , 2004 .
[2] W. Edmunds,et al. Impact of Model, Methodological, and Parameter Uncertainty in the Economic Analysis of Vaccination Programs , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] Joshua A. Salomon,et al. Exploring Model Uncertainty in Economic Evaluation of Health Interventions: The Example of Rotavirus Vaccination in Vietnam , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] Karl Claxton,et al. Defining and characterising structural uncertainty in decision analytic models , 2006 .
[5] M. Sculpher,et al. Modelling the long‐term cost‐effectiveness of endovascular or open repair for abdominal aortic aneurysm , 2007, The British journal of surgery.
[6] Andrew H. Briggs,et al. Handling Uncertainty in Cost-Effectiveness Models , 2000, PharmacoEconomics.
[7] A. O'Hagan,et al. Bayesian calibration of computer models , 2001 .
[8] David R. Anderson,et al. Model selection and multimodel inference : a practical information-theoretic approach , 2003 .
[9] Jonathan Karnon,et al. Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.
[10] Malcolm J Price,et al. Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] A. O'Hagan,et al. Statistical Methods for Eliciting Probability Distributions , 2005 .
[12] M C Downer,et al. The cost-effectiveness of screening for oral cancer in primary care. , 2006, Health technology assessment.
[13] J. Schellens,et al. The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance , 2013, PharmacoEconomics.
[14] Jonathan Karnon,et al. Specification and Implementation of Decision Analytic Model Structures for Economic Evaluation of Health Care Technologies , 2014 .
[15] Simon G Thompson,et al. Uncertainty and validation of health economic decision models. , 2009, Health economics.
[16] Karl Claxton,et al. Exploring Uncertainty in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.
[17] Karl Claxton,et al. A Framework for Addressing Structural Uncertainty in Decision Models , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] David Draper,et al. Assessment and Propagation of Model Uncertainty , 2011 .
[19] Karl Claxton,et al. Characterizing structural uncertainty in decision analytic models: a review and application of methods. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[21] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[22] Jörgen Möller,et al. Decision-Analytic Models: Current Methodological Challenges , 2014, PharmacoEconomics.
[23] Srikanta Mishra,et al. Model Averaging Techniques for Quantifying Conceptual Model Uncertainty , 2010, Ground water.
[24] Simon G Thompson,et al. Structural and parameter uncertainty in Bayesian cost-effectiveness models , 2010, Journal of the Royal Statistical Society. Series C, Applied statistics.
[25] J. Bryant,et al. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. , 2010, Health technology assessment.
[26] Jonathan Karnon,et al. Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern , 2022 .
[27] Jonathan Karnon,et al. A proposed model for economic evaluations of major depressive disorder , 2012, The European Journal of Health Economics.
[28] Simon G Thompson,et al. Accounting for uncertainty in health economic decision models by using model averaging , 2009, Journal of the Royal Statistical Society. Series A,.
[29] Jeremy E. Oakley,et al. Managing structural uncertainty in health economic decision models: a discrepancy approach , 2012 .
[30] S. Palmer,et al. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. , 2004, Health technology assessment.
[31] R. Mori,et al. Diagnosis of UTI: results of an evidence based approach to guideline development carried out for the National Institute for Health and Clinical Excellence (NICE) , 2008 .